Atlas Trials

Pentaglobin in CRE and PA Neutropenic Infections

Clinical trial NCT03494959 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03494959
Sponsor
Gruppo Italiano Trapianto di Midollo Osseo
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Septic Shock
Start date
2019-12-06
Primary completion
2024-05-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.